Substituted triazolo quinoxaline derivatives

US12110293B2 · kind B2 · utility

Assignee

• GRÜNENTHAL GMBH · DE

Inventors

• Florian Jakob · Aachen, DE
• Jo Alen · Averbode, BE
• Simon Lucas · Wien, AT
• Tobias Craan · Niedernberg, DE
• Ingo Konetzki · Warthausen, DE
• Achim Kless · Aachen, DE
• Stefan Schunk · Aachen, DE
• Paul Ratcliffe · Lanark, GB
• Sebastian Wachten · Bad Mergentheim, DE
• Simon Charles Cruwys · Coalville, GB

Key dates

• Filing date: Jan 20, 2021
• Grant date: Oct 8, 2024
• Expiry date: Mar 29, 2043

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P29/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.